✦ LIBER ✦

Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinoma

✍ Scribed by Terence C. Chua; Francis Chu; S. Patrick Butler; Richard J. Quinn; Derek Glenn; Winston Liauw; David L. Morris

Book ID: 102111100
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 204 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25283

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intra-arterial injection of iodine-131-l

Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma

✍ Eveline Boucher; Etienne Garin; Anne Guylligomarc’h; Damien Olivié; Karim Boudje 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Internal radiation by 131-iodine lipiodo

Internal radiation by 131-iodine lipiodol in unresectable hepatocellular carcinoma

✍ Tabone, Marco; Carbonatto, Paolo; Calvo, Amedeo; Pellerito, Riccardo; Stasi, Mic 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Adjuvant intra-arterial lipiodol-iodine-

Adjuvant intra-arterial lipiodol-iodine-131 for resectable hepatocellular carcinoma: a prospective randomised trial

✍ WY Lau; TWT Leung; SKW Ho; M Chan; D Machin; J Lau; ATC Chan; W Yeo; TSK Mok; SC 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 96 KB

TREATMENT OF UNRESECTABLE HEPATOCELLULAR

TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA WITH TRANSARTERIAL RADIOEMBOLIZATION: IODINE-131-LIPIODOL

✍ W. Y. Lau; Eric C. H. Lai 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Adjuvant intra-arterial injection of iod

Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma

✍ Eveline Boucher; Stéphane Corbinais; Yan Rolland; Patrick Bourguet; Dominique Gu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Epirubicin-lipiodol chemotherapy versus

Epirubicin-lipiodol chemotherapy versus 131iodine-lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma

✍ Satyajit Bhattacharya; Richard Novell; Geoffrey M. Dusheiko; Andrew J. Hilson; R 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 875 KB

Background. Arterially administered iodized oil (Lipiodol) is selectively retained by hepatocellular carcinomas (HCCs), and has been used as a vehicle for delivery of therapeutic agents to these tumors. This study compared the efficacy of Lipiodol-targeted epirubicin chemotherapy with Lipi~dol-'~lI